The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1.

BACKGROUND Granzyme B, one of the most abundant granzymes in cytotoxic T-lymphocyte (CTL) granules, and members of the caspase (cysteine aspartyl proteinases) family have a unique cleavage specificity for aspartic acid in P1 and play critical roles in the biochemical events that culminate in cell death. RESULTS We have determined the three-dimensional structure of the complex of the human granzyme B with a potent tetrapeptide aldehyde inhibitor. The Asp-specific S1 subsite of human granzyme B is significantly larger and less charged than the corresponding Asp-specific site in the apoptosis-promoting caspases, and also larger than the corresponding subsite in rat granzyme B. CONCLUSIONS The above differences account for the variation in substrate specificity among granzyme B, other serine proteases and the caspases, and enable the design of specific inhibitors that can probe the physiological functions of these proteins and the disease states with which they are associated.

[1]  A. Rosen,et al.  Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status , 1999, The Journal of experimental medicine.

[2]  N. Thornberry,et al.  Interleukin‐1βconverting enzyme: A novel cysteine protease required for IL‐1β production and implicated in programmed cell death , 1995, Protein science : a publication of the Protein Society.

[3]  L. Delbaere,et al.  The 1.8 A structure of the complex between chymostatin and Streptomyces griseus protease A. A model for serine protease catalytic tetrahedral intermediates. , 1985, Journal of molecular biology.

[4]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[5]  P. Henkart Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. , 1994, Immunity.

[6]  J. Berzofsky,et al.  Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. , 1997, Immunity.

[7]  D. Green,et al.  The cytotoxic cell protease granzyme B initiates apoptosis in a cell‐free system by proteolytic processing and activation of the ICE/CED‐3 family protease, CPP32, via a novel two‐step mechanism. , 1996, The EMBO journal.

[8]  Mark A. Murcko,et al.  Structure and mechanism of interleukin-lβ converting enzyme , 1994, Nature.

[9]  T. Ley,et al.  DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. , 2000, Immunity.

[10]  R. Huber,et al.  Structural basis of the endoproteinase-protein inhibitor interaction. , 2000, Biochimica et biophysica acta.

[11]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[12]  M. Grütter,et al.  The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. , 1999, Structure.

[13]  B. Finlay,et al.  Novel serine proteases encoded by two cytotoxic T lymphocyte-specific genes. , 1986, Science.

[14]  N. Thornberry,et al.  Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. , 1998, Immunity.

[15]  A. Tomasselli,et al.  The atomic-resolution structure of human caspase-8, a key activator of apoptosis. , 1999, Structure.

[16]  K. Wilson,et al.  The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. , 2000, Chemistry & biology.

[17]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[18]  Jennifer L. Harris,et al.  Definition and Redesign of the Extended Substrate Specificity of Granzyme B* , 1998, The Journal of Biological Chemistry.

[19]  Axel T. Brunger,et al.  Model bias in macromolecular crystal structures , 1992 .

[20]  C. Tellier,et al.  Diastereotopic covalent binding of the natural inhibitor leupeptin to trypsin: detection of two interconverting hemiacetals by solution and solid-state NMR spectroscopy. , 1991, Biochemistry.

[21]  N. Thornberry,et al.  The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis , 1996, Nature Structural Biology.

[22]  R. Huber,et al.  The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. , 1999, Journal of molecular biology.

[23]  S M Swanson,et al.  The structure of an insect chymotrypsin. , 2000, Journal of molecular biology.

[24]  J. Hollister,et al.  Engineering N-glycosylation pathways in the baculovirus-insect cell system. , 1998, Current opinion in biotechnology.

[25]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[26]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[27]  R. Zamboni,et al.  Purification and catalytic properties of human caspase family members , 1999, Cell Death and Differentiation.

[28]  I. Weissman,et al.  Comparative molecular model building of two serine proteinases from cytotoxic T lymphocytes , 1990, Proteins.

[29]  G Berke,et al.  The CTL's kiss of death , 1995, Cell.

[30]  P. Argos,et al.  Knowledge‐based protein secondary structure assignment , 1995, Proteins.

[31]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[32]  J. Sack,et al.  CHAIN — A crystallographic modeling program , 1988 .

[33]  L. Hellman,et al.  Secretory Granule Proteases in Rat Mast Cells. Cloning of 10 Different Serine Proteases and a Carboxypeptidase A from Various Rat Mast Cell Populations , 1997, The Journal of experimental medicine.

[34]  N H Sigal,et al.  Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity. , 1991, The Journal of biological chemistry.

[35]  Hans Neurath,et al.  The structure of rat mast cell protease II at 1.9-A resolution. , 1984, Biochemistry.

[36]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[37]  R. Huber,et al.  The 1.8 A crystal structure of human cathepsin G in complex with Suc‐Val‐Pro‐PheP‐(OPh)2: a Janus‐faced proteinase with two opposite specificities. , 1996, The EMBO journal.

[38]  L. Juliano,et al.  New, Sensitive Fluorogenic Substrates for Human Cathepsin G Based on the Sequence of Serpin-reactive Site Loops* , 1999, The Journal of Biological Chemistry.

[39]  Timothy J. Ley,et al.  Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells , 1994, Cell.

[40]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[41]  R. Bleackley,et al.  Mechanisms of lysis by cytotoxic T cells. , 1995, Critical reviews in immunology.

[42]  Robert Fletterick,et al.  The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity , 2000, Nature Structural Biology.

[43]  J. Mankovich,et al.  Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 homodimer , 1994, Cell.

[44]  M. Peitsch,et al.  [5] Granzyme B , 1994 .

[45]  D. Nicholson,et al.  Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B , 1995, Nature.

[46]  R. Aebersold,et al.  A natural killer cell granule protein that induces DNA fragmentation and apoptosis , 1992, The Journal of experimental medicine.

[47]  G J Kleywegt,et al.  Software for handling macromolecular envelopes. , 1999, Acta crystallographica. Section D, Biological crystallography.

[48]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.